{
    "title": "108_hr3458",
    "content": "The Act may be cited as the \"Diabetic Retinopathy Prevention Act of 2003\". It includes findings related to diabetic retinopathy prevention. The Congress finds that type 2 diabetes affects millions of Americans, costing billions annually. Diabetic retinopathy, a common complication, leads to vision loss and blindness. Early detection and treatment can reduce vision loss by 90 percent. Early detection and treatment of diabetic retinopathy can reduce vision loss by 90 percent, with remote assessment having the potential to reach diabetic patients in underserved areas. Medicare coverage is expanded to include remote assessment of diabetic retinopathy, aiming to reach underserved diabetic patients. The term 'remote assessment of diabetic retinopathy' refers to a diagnostic examination of the retina for early detection of diabetic retinopathy, provided annually to individuals with diabetes. The examination must meet technical standards set by the Secretary and be conducted via a telecommunications system by qualified healthcare professionals. Payment is allowed regardless of the location of the healthcare provider. The Act allows for remote assessments of diabetic retinopathy to be provided to eligible patients through store-and-forward technologies, with payment being made regardless of the location of the healthcare provider. Interim payment will be provided until final regulations are published by the Secretary of Health and Human Services. During the interim period after the Act's enactment, the Secretary of Health and Human Services will ensure payment for retinopathy assessments and assign temporary HCPCS codes. A study on costs for remote diabetic retinopathy assessments will be conducted within a year, with a report and recommendations due to Congress within two years. The Secretary will submit a report to Congress within 2 years on the study of costs for remote diabetic retinopathy assessments, including recommendations on reimbursements under Medicare and the need for future studies. The amendments will apply 30 days after the Act's enactment. Medicaid coverage for remote assessment of diabetic retinopathy. The Social Security Act is amended to include remote assessment of diabetic retinopathy for Medicaid coverage. The effective date for these amendments is upon enactment of the Act. States needing legislation to comply with the new requirement will not be penalized if they meet it within a specified timeframe after the Act's enactment. States must comply with the new requirement for remote assessment of diabetic retinopathy for Medicaid coverage within a specified timeframe after the Act's enactment. If a State has a 2-year legislative session, each year of the session is considered a separate regular session of the State legislature. SEC. 5. MOBILE DIABETIC RETINOPATHY SCREENING PILOT PROGRAM. Amends Title III of the Public Health Service Act to establish a pilot program for mobile diabetic retinopathy screening. The Secretary will establish a grant program called the \"Mobile Diabetic Retinopathy Screening Pilot Program\" to provide grants to 5 eligible entities for setting up mobile diabetic retinopathy screening programs. Grants cannot exceed $1,000,000 per year, and entities must agree to use the funds for designing, demonstrating, and implementing the screening program. The Secretary will solicit applications for grants within 90 days of funds becoming available. The Secretary will prioritize grant applicants with experience in diabetic retinopathy evaluation using telecommunications equipment and serving rural, impoverished, minority, and remote populations. The Secretary will prioritize grant applicants with experience in diabetic retinopathy evaluation using telecommunications equipment and serving rural, impoverished, minority, and remote populations. Congressional notification is required before making a grant, and an evaluation of the Mobile Diabetic Retinopathy Screening Pilot Program will be conducted to assess its effectiveness in early detection and prevention measures. The advisory committee will evaluate the effectiveness of the Program in increasing early detection of diabetic retinopathy and reducing its prevalence. They will also assess if the program can be a model for screening programs for other chronic conditions. A report will be submitted to Congress within 42 months of the first grant. The Secretary will submit a report to Congress within 42 months of the first grant, containing the results of the advisory committee's evaluation. Definitions include terms like 'advisory committee', 'eligible entity', and 'mobile diabetic retinopathy screening program'. The Mobile Diabetic Retinopathy Screening Pilot Program offers remote assessment of diabetic retinopathy for patients in rural areas. $5,000,000 is authorized for fiscal years 2005-2009 for program implementation."
}